Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV7909 for Post-Exposure Prophylaxis of Anthrax
NCT01770743Phase 2Completed
- Sponsor
- Emergent BioSolutions
- Start
- Jan 2013
- Primary completion
- Feb 2014
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of NuThrax in anthrax, sponsored by Emergent BioSolutions. Started Jan 2013; status: completed.
02
Drugs
NuThrax
03
Conditions
anthrax
Beyond the preview
Go deeper on NCT01770743.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01770743.